돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 323501생성일: 2026년 10월 24일

Tecastemizole → 1-(3,4,5-trimethoxybenzyl)-3-(3-(4-(1-(4-fluorobenzyl)-1H-benzimidazol-2-yl-amino)piperidin-1-yl)propyl)-3-(4-fluorophenylmethyl)-2-oxopyrrolidine

https://huagongshe.com/ko/reaction/323501

반응식

참여 물질

역할이름HCID투입량
반응물TecastemizoleHCID 123618—
반응물1-(3,4,5-Trimethoxybenzyl)-3-(4-fluorophenylmethyl)-3-(3-methanesulfonyloxypropyl)-2-oxopyrrolidineHCID 18464483—
생성물1-(3,4,5-trimethoxybenzyl)-3-(3-(4-(1-(4-fluorobenzyl)-1H-benzimidazol-2-yl-amino)piperidin-1-yl)propyl)-3-(4-fluorophenylmethyl)-2-oxopyrrolidineHCID 9918400—

반응 단계

Prepare by the method of Example 23.4 using 1-(3,4,5-trimethoxybenzyl)-3-(4-fluorophenylmethyl)-3-(3-methanesulfonyloxypropyl)-2-oxopyrrolidine and (1-(4-fluorobenzyl)-1H-benzimidazol-2-yl)(piperidin-4-yl)amine to give the title compound.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06211199B1
출처 데이터셋uspto-grants-2001_04
ORD IDord-9e44a0d99e324b64b42383ea1ab24496
출처 메모uspto-grants-2001_04